Curatis starts 2a clinical trial of adult tuberculosis vaccine this January
Curatis, an immune vaccine and immunotherapy company, announced to conduct a Phase 2a clinical trial of tuberculosis preventive vaccine for adults at Yonsei University Severance Hospital this January. The company acquired IND(Investigational New Drug) approval for the Phase 2a clinical trial of a...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.